The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome
Authors:
- Alicia Rodríguez-PasténARAlicia Rodríguez-Pastén
- Nury Pérez-HernándezNury Pérez-Hernández
- Javier Añorve-MorgaJAJavier Añorve-Morga
- Rubén Jiménez-AlvaradoRJRubén Jiménez-Alvarado
- Raquel Cariño-CortésRCRaquel Cariño-Cortés
- Teresa Sosa-LozadaTSTeresa Sosa-Lozada
- Eduardo Fernández-MartínezEFEduardo Fernández-Martínez
Open Access
- 29 June 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (13) , 7229
Abstract
The components of metabolic syndrome (MetS) and hepatogastrointestinal diseases are widespread worldwide, since many factors associated with lifestyle and diet influence their development and correlation. Due to these growing health problems, it is necessary to search for effective alternatives for prevention or adjuvants in treating them. The positive impact of regulated microbiota on health is known; however, states of dysbiosis are closely related to the development of the conditions mentioned above. Therefore, the role of prebiotics, probiotics, or symbiotic complexes has been extensively evaluated; the results are favorable, showing that they play a crucial role in the regulation of the immune system, the metabolism of carbohydrates and lipids, and the biotransformation of bile acids, as well as the modulation of their central receptors FXR and TGR-5, which also have essential immunomodulatory and metabolic activities. It has also been observed that they can benefit the host by displacing pathogenic species, improving the dysbiosis state in MetS. Current studies have reported that paraprobiotics (dead or inactive probiotics) or postbiotics (metabolites generated by active probiotics) also benefit hepatogastrointestinal health.Keywords
This publication has 128 references indexed in Scilit:
- Immunological Properties of Inulin-Type FructansCritical Reviews in Food Science and Nutrition, 2014
- Postbiotics: what else?Beneficial Microbes, 2013
- Bile Acid Signaling in Liver Metabolism and DiseasesJournal of Lipids, 2012
- Polydextrose Enrichment of Infant Formula Demonstrates Prebiotic Characteristics by Altering Intestinal Microbiota, Organic Acid Concentrations, and Cytokine Expression in Suckling PigletsThe Journal of Nutrition, 2011
- Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disordersTherapeutic Advances in Gastroenterology, 2011
- Regulation of Inflammation by Short Chain Fatty AcidsNutrients, 2011
- Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndromeBritish Journal of Nutrition, 2011
- The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept)Genes & Nutrition, 2011
- Metabolic Endotoxemia Initiates Obesity and Insulin ResistanceDiabetes, 2007
- The specificity of the interaction with intestinal bacterial fermentation by prebiotics determines their physiological efficacyNutrition Research Reviews, 2004